PROG
Income statement / Annual
Last year (2021), Biora Therapeutics, Inc.'s total revenue was $1.25 M,
a decrease of 98.32% from the previous year.
In 2021, Biora Therapeutics, Inc.'s net income was -$178.52 M.
See Biora Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$1.25 M |
$74.31 M |
$143.99 M |
$127.97 M |
| Cost of Revenue |
$0.00
|
$93.43 M
|
$100.49 M
|
$92.08 M
|
| Gross Profit |
$1.25 M
|
-$19.12 M
|
$43.49 M
|
$35.90 M
|
| Gross Profit Ratio |
1
|
-0.26
|
0.3
|
0.28
|
| Research and Development Expenses |
$45.79 M
|
$47.74 M
|
$63.40 M
|
$48.71 M
|
| General & Administrative Expenses |
$68.54 M
|
$75.44 M
|
$61.32 M
|
$51.24 M
|
| Selling & Marketing Expenses |
$4.76 M
|
$52.89 M
|
$58.89 M
|
$50.19 M
|
| Selling, General & Administrative Expenses |
$73.30 M
|
$128.33 M
|
$120.21 M
|
$101.43 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$119.08 M
|
$176.07 M
|
$183.61 M
|
$150.14 M
|
| Cost And Expenses |
$119.08 M
|
$269.50 M
|
$284.10 M
|
$242.21 M
|
| Interest Income |
$0.00
|
$0.00
|
$575.00 K
|
$1.80 M
|
| Interest Expense |
$12.64 M
|
$34.87 M
|
$9.20 M
|
$9.09 M
|
| Depreciation & Amortization |
$1.44 M
|
$5.06 M
|
$6.35 M
|
$6.07 M
|
| EBITDA |
-$164.57 M |
-$190.13 M |
-$133.20 M |
-$108.69 M |
| EBITDA Ratio |
-131.97
|
-2.56
|
-0.93
|
-0.85
|
| Operating Income Ratio |
-188.37
|
-2.63
|
-0.97
|
-0.89
|
| Total Other Income/Expenses Net |
$56.26 M
|
-$34.87 M
|
-$8.62 M
|
-$9.62 M
|
| Income Before Tax |
-$178.64 M
|
-$230.06 M
|
-$148.74 M
|
-$123.86 M
|
| Income Before Tax Ratio |
-143.26
|
-3.1
|
-1.03
|
-0.97
|
| Income Tax Expense |
-$119.00 K
|
-$37.53 M
|
-$706.00 K
|
$5.25 M
|
| Net Income |
-$178.52 M
|
-$192.53 M
|
-$148.04 M
|
-$129.11 M
|
| Net Income Ratio |
-143.16
|
-2.59
|
-1.03
|
-1.01
|
| EPS |
-6.49 |
-7 |
-5.49 |
-4.79 |
| EPS Diluted |
-6.49 |
-7 |
-5.49 |
-4.79 |
| Weighted Average Shares Out |
$27.51 M
|
$27.51 M
|
$26.96 M
|
$26.96 M
|
| Weighted Average Shares Out Diluted |
$27.51 M
|
$27.51 M
|
$26.96 M
|
$26.96 M
|
| Link |
|
|
|
|
